Latest Headlines

  1. Registration Opens For INTERPHEX 2025 | April 1-3 In NYC: Learning Lab Conference Schedule, Show Floor Content, And New Features Announced 1/16/2025

    Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place April 1-3, 2025, at the Javits Center in NYC. Here, attendees gain direct access to the tools they need to effectively accelerate their drug-to-market journey.

  2. Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025 1/14/2025

    Wake Forest, NC, USA | Adelaide, Australia

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.

    Book a meeting with the Avance Clinical team at Biotech Showcase.

  3. Nucleus Biologics Becomes First Custom Cell Culture Media Company To Achieve EXCiPACT Certification For The Manufacture Of Excipient GMP Quality Cell Culture Media, Supplements, And Buffers 1/9/2025

    Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS.

  4. Astraveus Announces World First End-To-End Production of CAR-T Cells Using Microfluidic Technology 1/9/2025

    Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Using its fully automated Lakhesys Benchtop Cell FactoryTM, Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing approach, which has the ability to decrease manufacturing costs and increase throughput by an order of magnitude.

  5. CRB Announces Exhibition And Speaker Schedule For Advanced Therapies Week 2025 1/9/2025

    Attending the show? Make sure to meet CRB’s team of cell and gene therapy specialists at Advanced Therapies Week in booth 566. CRB’s subject matter expert, Peter Walters, will be presenting an educational seminar in the session “Developing Future Facilities While Supporting the Advanced Therapies Ecosystem."

  6. Pandorum Partners With AGC Biologics To Support Clinical Manufacturing Of Exosome-Based Kuragenx, A Treatment Of Ulcerative Corneal Blindness 1/8/2025

    AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a partnership with Pandorum to produce their flagship product Kuragenx—the 'liquid cornea'—a combination biologic.

  7. Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape 12/30/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.

  8. Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories 12/30/2024

    Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.

  9. Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape 12/30/2024

    The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."

  10. AES Clean Technology Names Former CRB Executive To Drive Western Region Growth 12/20/2024

    AES Clean Technology, a leading provider of high-performance cleanroom facilities, has today announced the appointment of Jeff Rozelle as Senior Vice President of Business Development, West Region.